236 related articles for article (PubMed ID: 25983967)
1. Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.
Goto S; Komaba H; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii2-iii8. PubMed ID: 25983967
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.
Fukagawa M; Kitaoka M; Tominaga Y; Akizawa T; Kakuta T; Onoda N; Koiwa F; Yumita S; Kurokawa K;
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii31-3. PubMed ID: 12771296
[TBL] [Abstract][Full Text] [Related]
3. Medical management after parathyroid intervention.
Tanaka M; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966
[TBL] [Abstract][Full Text] [Related]
4. Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
Fukagawa M; Nakanishi S; Kazama JJ
Kidney Int Suppl; 2006 Jul; (102):S3-7. PubMed ID: 16810308
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.
Fukagawa M; Kitaoka M; Kurokawa K
Nephrol Dial Transplant; 1996; 11 Suppl 3():125-9. PubMed ID: 8840327
[TBL] [Abstract][Full Text] [Related]
6. Medical and surgical aspects of parathyroidectomy.
Fukagawa M; Tominaga Y; Kitaoka M; Kakuta T; Kurokawa K
Kidney Int Suppl; 1999 Dec; 73():S65-9. PubMed ID: 10633467
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and medical treatment of secondary hyperparathyroidism.
Fukagawa M; Kurokawa K
Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
9. Indication and efficacy of PEIT in the management of secondary hyperparathyroidism.
Koiwa F; Hasegawa T; Tanaka R; Kakuta T
NDT Plus; 2008 Aug; 1(Suppl 3):iii14-iii17. PubMed ID: 25983965
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Kunimatsu K; Tadaki F; Fujisaki T; Noguchi M; Abe Y; Sakai H; Kurokawa K; Saito A
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():60s-65s. PubMed ID: 10914993
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonography methods in the diagnosis of renal osteodystrophy].
Tomić-Brzac H; Pavlović D
Acta Med Croatica; 2004; 58(1):43-9. PubMed ID: 15125393
[TBL] [Abstract][Full Text] [Related]
12. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
13. New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.
Onoda N; Fukagawa M; Tominaga Y; Kitaoka M; Akizawa T; Koiwa F; Kakuta T; Kurokawa K;
NDT Plus; 2008 Aug; 1(Suppl 3):iii26-iii28. PubMed ID: 25983969
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism.
de Barros Gueiros JE; Chammas MC; Gerhard R; da Silva Dias Boilesen CF; de Oliveira IR; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2004 Mar; 19(3):657-63. PubMed ID: 14767023
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.
Kakuta T; Fukagawa M; Kitaoka M; Koiwa F; Onoda N; Tominaga Y; Akizawa T; Kurokawa K;
NDT Plus; 2008 Aug; 1(Suppl 3):iii21-iii25. PubMed ID: 25983968
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
Koiwa F; Kakuta T; Tanaka R; Yumita S
Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
20. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
